| Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation CH Andreasen, KL Stender-Petersen, MS Mogensen, SS Torekov, ... Diabetes 57 (1), 95-101, 2008 | 545 | 2008 |
| Impact of postprandial glycaemia on health and prevention of disease EE Blaak, JM Antoine, D Benton, I Björck, L Bozzetto, F Brouns, ... obesity reviews 13 (10), 923-984, 2012 | 207 | 2012 |
| An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the future S Madsbad, U Kielgast, M Asmar, CF Deacon, SS Torekov, JJ Holst Diabetes, Obesity and Metabolism 13 (5), 394-407, 2011 | 191 | 2011 |
| GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ... Diabetes 64 (7), 2513-2525, 2015 | 117 | 2015 |
| Proteomics reveals the effects of sustained weight loss on the human plasma proteome PE Geyer, NJW Albrechtsen, S Tyanova, N Grassl, EW Iepsen, ... Molecular systems biology 12 (12), 2016 | 70 | 2016 |
| GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women EW Iepsen, JR Lundgren, B Hartmann, O Pedersen, T Hansen, ... The Journal of Clinical Endocrinology & Metabolism 100 (8), 2909-2917, 2015 | 68 | 2015 |
| Association between neuromedin U gene variants and overweight and obesity I Hainerová, SS Torekov, J Ek, M Finková, K Borch-Johnsen, T Jørgensen, ... The Journal of Clinical Endocrinology & Metabolism 91 (12), 5057-5063, 2006 | 61 | 2006 |
| Obesity–an indication for GLP‐1 treatment? Obesity pathophysiology and GLP‐1 treatment potential SS Torekov, S Madsbad, JJ Holst obesity reviews 12 (8), 593-601, 2011 | 59 | 2011 |
| Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss EW Iepsen, J Lundgren, C Dirksen, JEB Jensen, O Pedersen, T Hansen, ... International Journal of Obesity 39 (5), 834-841, 2015 | 58 | 2015 |
| Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation K Færch, D Vistisen, G Pacini, SS Torekov, NB Johansen, DR Witte, ... Diabetes 65 (11), 3473-3481, 2016 | 57 | 2016 |
| A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased … SS Torekov, T Harsløf, L Rejnmark, P Eiken, JB Jensen, AP Herman, ... The Journal of Clinical Endocrinology & Metabolism 99 (4), E729-E733, 2014 | 47 | 2014 |
| Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3–36 EW Iepsen, J Lundgren, JJ Holst, S Madsbad, SS Torekov European journal of endocrinology 174 (6), 775-784, 2016 | 41 | 2016 |
| KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia SS Torekov, E Iepsen, M Christiansen, A Linneberg, O Pedersen, JJ Holst, ... Diabetes 63 (4), 1315-1325, 2014 | 41 | 2014 |
| Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes SS Torekov, LH Larsen, C Glümer, K Borch-Johnsen, T Jørgensen, ... Diabetes 54 (7), 2261-2265, 2005 | 41 | 2005 |
| Liraglutide for Type 2 diabetes and obesity: a 2015 update EW Iepsen, SS Torekov, JJ Holst Expert review of cardiovascular therapy 13 (7), 753-767, 2015 | 40 | 2015 |
| Therapies for inter-relating diabetes and obesity–GLP-1 and obesity EW Iepsen, SS Torekov, JJ Holst Expert opinion on pharmacotherapy 15 (17), 2487-2500, 2014 | 35 | 2014 |
| Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects SS Torekov, LH Larsen, G Andersen, A Albrechtsen, C Glümer, ... Diabetologia 49 (11), 2653-2658, 2006 | 27 | 2006 |
| Glucose-dependent insulinotropic polypeptide is associated with lower low-density lipoprotein but unhealthy fat distribution, independent of insulin: the ADDITION-PRO Study CL Møller, D Vistisen, K Færch, NB Johansen, DR Witte, A Jonsson, ... The Journal of Clinical Endocrinology & Metabolism 101 (2), 485-493, 2016 | 24* | 2016 |
| Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon … SS Torekov, L Ma, N Grarup, B Hartmann, IA Hainerova, U Kielgast, ... Diabetologia 54 (11), 2820, 2011 | 20 | 2011 |
| Dose response of subcutaneous GLP‐1 infusion in patients with type 2 diabetes SS Torekov, MS Kipnes, RE Harley, JJ Holst, MR Ehlers Diabetes, Obesity and Metabolism 13 (7), 639-643, 2011 | 20 | 2011 |
Oluf PedersenProfessor of Metabolic Genetics, University of CopenhagenVerified email at sund.ku.dk
